Markets:

Overview

News

Currencies

International

Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

3.460 +0.380 (+12.34%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 20, 2023

Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates...

Via Benzinga

Anavex Stock Is Moving Higher Monday: What's Going On? ↗

November 20, 2023

Anavex Life Sciences Corp (NASDAQ: AVXL) shares are trading higher Monday.

Via Benzinga

General Dynamics, Microsoft, Waste Management And Other Big Stocks Moving Higher On Wednesday ↗

October 25, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Preview: Anavex Life Sciences's Earnings ↗

August 07, 2023

Via Benzinga

The Latest Analyst Ratings for Anavex Life Sciences ↗

May 02, 2023

Via Benzinga

Analyst Ratings for Anavex Life Sciences ↗

March 31, 2023

Via Benzinga

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗

August 09, 2023

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.

Via Benzinga

This Short-Squeeze Candidate Could Actually Pan Out in the Long Run ↗

February 09, 2023

Short-sellers have piled into this clinical-stage biopharma stock.

Via The Motley Fool

Earnings Preview: Anavex Life Sciences ↗

February 06, 2023

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today ↗

January 10, 2023

Via Benzinga

Here's How Much $100 Invested In Anavex Life Sciences 5 Years Ago Would Be Worth Today ↗

December 27, 2022

Via Benzinga

Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday ↗

August 09, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Anavex Life Sciences Releases Encouraging Long Term Data From Rett Syndrome Study ↗

June 28, 2023

Anavex Life Sciences Corp (NASDAQ: AVXL) announced that long-term clinical study results from the U.S.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

May 26, 2023

Via Benzinga

What's Going On With Anavex Life Sciences Shares Today? ↗

March 30, 2023

Anavex Life Sciences Corp (NASDAQ: AVXL) shares are trading higher Thursday after the company reported results from its Phase 2 study in patients with Parkinson's disease dementia showing beneficial...

Via Benzinga

Here's How Much You Would Have Made Owning Anavex Life Sciences Stock In The Last 5 Years ↗

December 08, 2022

Via Benzinga

Wall Street Thinks This Small-Cap Stock Can Quadruple in Value ↗

March 15, 2023

The company generates no revenue, but it may be worth taking a chance on as it possesses lots of upside.

Via The Motley Fool

Why Shares of Anavex Life Sciences Rose 12.4% in February ↗

March 06, 2023

The company's first-quarter earnings report detailed positive news regarding its pipeline.

Via The Motley Fool

Is Anavex Life Sciences Stock a Buy Now? ↗

February 23, 2023

A short squeeze could be a possibility if the company can prove that bearish investors are wrong about its business.

Via The Motley Fool

Why Anavex Life Sciences Stock Bolted Higher in January ↗

February 08, 2023

The biotech's shares have been steadily leaking higher following positive late-stage Alzheimer's disease trial results.

Via The Motley Fool

Anavex Life Sciences Stock Shows Improved Price Strength Rating ↗

February 07, 2023

Anavex Life Sciences stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 75.

Via Investor's Business Daily

3 Biotech Stocks Under $15 Worth a Second Look in 2023 ↗

January 18, 2023

All three stocks have promising therapies that could drive revenue in the coming years.

Via The Motley Fool

Top Picks For 2023: Anavex Life Sciences ↗

January 06, 2023

Anavex is a biopharmaceutical company dedicated to the development of novel drug candidates to treat central nervous system diseases, with encouraging results in Alzheimer’s, Parkinson’s, and Rett...

Via Talk Markets

Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday ↗

January 03, 2023

Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market...

Via Benzinga

Analyzing Anavex Life Sciences's Short Interest ↗

December 21, 2022

Anavex Life Sciences's (NASDAQ:AVXL) short percent of float has risen 17.06% since its last report. The company recently reported that it has 11.91 million shares sold short, which is 15.71% of all...

Via Benzinga

Anavex Life Sciences Stock Could 5x Before 2025 -- Here's Why ↗

December 17, 2022

The biotech will first need to assuage the concerns of experts by elaborating on its latest clinical trial data.

Via The Motley Fool

Is Anavex Life Sciences a Buy? ↗

December 13, 2022

It still needs to prove that its lead program is as effective as it claims for treating Alzheimer's.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗

December 06, 2022

Via Benzinga

Is Anavex Life Sciences a Smart Stock to Buy Now? ↗

December 03, 2022

The company's Alzheimer's disease drug just succeeded in a clinical trial. Or did it?

Via The Motley Fool

Dow Drops 100 Points; Asana Shares Plummet ↗

December 02, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling around 100 points on Friday.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

All News about Anavex Life Sciences Corp. - Common Stock

Starting at $3.75/week.

Subscribe Today